首页 > 最新文献

Journal of opioid management最新文献

英文 中文
Short-term healthcare resource utilization associated with receipt of CDC-informed opioid thresholds among commercially insured new chronic opioid users 商业保险新慢性阿片类药物使用者接受疾病预防控制中心提供的阿片类药物阈值后的短期医疗资源利用情况
Q3 Medicine Pub Date : 2024-02-08 DOI: 10.5055/jom.0848
Martin J. Calabrese, F. Shaya, Francis Palumbo, M. Mcpherson, Ester Villalonga-Olives, Z. Zafari, Ryan Mutter
Objective: To evaluate the impact of recent changes to the Centers for Disease Control and Prevention (CDC) morphine milligram equivalent (MME)/day threshold recommendations on healthcare utilization. Design: A retrospective cohort study of new chronic opioid users (NCOUs). Setting: Commercially insured plans across the United States using IQVIA PharMetrics® Plus for Academics database with new use between January 2014 and March 2015. Patients: NCOUs with ≥60-day coverage of opioids within a 90-day period with ≥30-day opioid-free period prior to the date of the first qualifying opioid prescription. Interventions: NCOU categorized by the CDC three-tiered risk-based average MME/day thresholds: low (>0 to <50), medium (≥50 to <90), and high (≥90). Main outcome measures: Multivariable logistic regression was used to calculate adjusted odds of incurring an acute care encounter (ACE) (all-cause and opioid related) between the thresholds (adjusted odds, 95 percent confidence interval). Results: In adjusted analyses, when compared to low threshold, there was no difference in the odds of all-cause ACE across the medium (1.01, 0.94-1.28) and high (1.01, 0.84-1.22) thresholds. When compared to low threshold, a statistically insignificant increase was observed when evaluating opioid-related ACE among medium (1.86, 0.86-4.02) and high (1.51, 0.65-3.52) thresholds. Conclusions: There was no difference in odds of an all-cause or opioid-related ACE associated with the thresholds. Early-intervention programs and policies exploring reduction of MME/day among NCOUs may not result in short-term reduction in all-cause or opioid-related ACEs. Further assessment of potential long-term reduction in ACEs among this cohort may be insightful.  
目的:评估美国疾病控制和预防中心(CDC)吗啡毫克当量(MME)/天阈值建议的最新变化对医疗保健使用的影响。设计:对新的慢性阿片类药物使用者(NCOUs)进行回顾性队列研究。地点:美国使用 IQVIA PharMetrics® Plus for Academics 数据库的全美商业保险计划,2014 年 1 月至 2015 年 3 月期间的新增使用情况。患者:在首次开具合格阿片类药物处方日期之前的 90 天内,阿片类药物投保期≥60 天且无阿片类药物投保期≥30 天的 NCOU。干预措施:按疾病预防控制中心基于风险的三级平均 MME/天阈值对 NCOU 进行分类:低(>0 至 <50)、中(≥50 至 <90)和高(≥90)。主要结果测量:采用多变量逻辑回归法计算不同阈值之间发生急性护理事件(ACE)(全因和阿片类药物相关)的调整后几率(调整后几率,95% 置信区间)。结果:在调整分析中,与低阈值相比,中阈值(1.01,0.94-1.28)和高阈值(1.01,0.84-1.22)发生全因急性护理事件的几率没有差异。与低阈值相比,中阈值(1.86,0.86-4.02)和高阈值(1.51,0.65-3.52)在评估阿片类药物相关的 ACE 时,观察到了统计学上不显著的增加。结论与阈值相关的全因或阿片类药物相关的ACE几率没有差异。早期干预计划和政策探索减少 NCOU 的 MME/天数可能不会在短期内减少全因或阿片类药物相关的 ACE。进一步评估该群体中 ACE 的长期减少潜力可能会有所启发。
{"title":"Short-term healthcare resource utilization associated with receipt of CDC-informed opioid thresholds among commercially insured new chronic opioid users","authors":"Martin J. Calabrese, F. Shaya, Francis Palumbo, M. Mcpherson, Ester Villalonga-Olives, Z. Zafari, Ryan Mutter","doi":"10.5055/jom.0848","DOIUrl":"https://doi.org/10.5055/jom.0848","url":null,"abstract":"Objective: To evaluate the impact of recent changes to the Centers for Disease Control and Prevention (CDC) morphine milligram equivalent (MME)/day threshold recommendations on healthcare utilization. \u0000Design: A retrospective cohort study of new chronic opioid users (NCOUs). \u0000Setting: Commercially insured plans across the United States using IQVIA PharMetrics® Plus for Academics database with new use between January 2014 and March 2015. \u0000Patients: NCOUs with ≥60-day coverage of opioids within a 90-day period with ≥30-day opioid-free period prior to the date of the first qualifying opioid prescription. \u0000Interventions: NCOU categorized by the CDC three-tiered risk-based average MME/day thresholds: low (>0 to <50), medium (≥50 to <90), and high (≥90). \u0000Main outcome measures: Multivariable logistic regression was used to calculate adjusted odds of incurring an acute care encounter (ACE) (all-cause and opioid related) between the thresholds (adjusted odds, 95 percent confidence interval). \u0000Results: In adjusted analyses, when compared to low threshold, there was no difference in the odds of all-cause ACE across the medium (1.01, 0.94-1.28) and high (1.01, 0.84-1.22) thresholds. When compared to low threshold, a statistically insignificant increase was observed when evaluating opioid-related ACE among medium (1.86, 0.86-4.02) and high (1.51, 0.65-3.52) thresholds. \u0000Conclusions: There was no difference in odds of an all-cause or opioid-related ACE associated with the thresholds. Early-intervention programs and policies exploring reduction of MME/day among NCOUs may not result in short-term reduction in all-cause or opioid-related ACEs. Further assessment of potential long-term reduction in ACEs among this cohort may be insightful. \u0000 ","PeriodicalId":16601,"journal":{"name":"Journal of opioid management","volume":"30 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139853175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of opioid use in gastrointestinal obstruction and perforation: A retrospective review 阿片类药物在胃肠道梗阻和穿孔中的作用:回顾性研究
Q3 Medicine Pub Date : 2024-02-08 DOI: 10.5055/jom.0850
Divya Bishnoi, Priyanka Sharma, A. K. Rathi
Introduction: Pain is one of the most common complaints that brings a patient to a hospital. For this, usually, the patient might have already consumed various types of pain killer combinations, either prescribed or over-the-counter. In some of these cases, a patient consumes these medicines unmonitored for a long time and then comes with complications, among which gastrointestinal tract obstruction and perforation are the most life threatening. Materials and methods: Case files from the Department of Surgery were retrieved and studied. Patients were contacted telephonically for details of drug abuse history. These were then further studied in detail. Results: Forty-eight (68 percent) patients out of a total of 78 had a history of drug abuse. The most commonly abused pain killer was a combination of anti-inflammatory and other salts, which was found in 22 (46 percent) patients, followed by tramadol, NSAIDs, opium, and alcohol (23, 17, 10, and 4 percent, respectively). These groups were comparable in socio-demographic details except in the mean age, occupation, and gender distribution, and the difference was significant (p < 0.01). The most common cause for starting to use any of the above-mentioned pain killer was persistent pain. The most common site of obstruction in drug abusers was the stomach (60 percent), followed by the small intestine (38 percent) and the large intestine (2 percent). Limitations: (1) This is an observational retrospective record review. (2) Records were studied in hospital settings, so results should be generalized cautiously. (3) Risk of recall bias is present. Conclusion: Pain killers should always be prescribed with caution and for a short duration. Alternative options for pain relief should be made available, and doctors should be trained. Drug abusers tend to have a gastrointestinal complication at an early age, which means they are prone to further complications and recurrence if the problem is not addressed on time.
简介疼痛是病人到医院就诊最常见的主诉之一。通常情况下,病人可能已经服用了各种止痛药,包括处方药或非处方药。在某些情况下,患者在长期服用这些药物而未接受监测的情况下,会出现并发症,其中胃肠道梗阻和穿孔最有生命危险。材料和方法:检索并研究了外科部门的病例档案。通过电话与患者取得联系,详细了解其药物滥用史。然后对这些资料进行进一步详细研究。研究结果在总共 78 名患者中,有 48 名(68%)有药物滥用史。最常滥用的止痛药是消炎药和其他盐类的复方制剂,在 22 名(46%)患者中发现,其次是曲马多、非甾体抗炎药、鸦片和酒精(分别占 23%、17%、10% 和 4%)。除平均年龄、职业和性别分布外,这几组患者在社会人口学细节方面具有可比性,且差异显著(P < 0.01)。开始使用上述任何一种止痛剂的最常见原因是持续性疼痛。药物滥用者最常见的梗阻部位是胃(60%),其次是小肠(38%)和大肠(2%)。局限性:(1)这是一项观察性回顾记录研究。(2)记录是在医院环境中研究的,因此应谨慎推广结果。(3)存在回忆偏差的风险。结论:应谨慎使用止痛药,且用药时间不宜过长。应提供其他缓解疼痛的方法,并对医生进行培训。药物滥用者往往很早就出现胃肠道并发症,这意味着如果不及时处理问题,他们很容易出现进一步的并发症和复发。
{"title":"Role of opioid use in gastrointestinal obstruction and perforation: A retrospective review","authors":"Divya Bishnoi, Priyanka Sharma, A. K. Rathi","doi":"10.5055/jom.0850","DOIUrl":"https://doi.org/10.5055/jom.0850","url":null,"abstract":"Introduction: Pain is one of the most common complaints that brings a patient to a hospital. For this, usually, the patient might have already consumed various types of pain killer combinations, either prescribed or over-the-counter. In some of these cases, a patient consumes these medicines unmonitored for a long time and then comes with complications, among which gastrointestinal tract obstruction and perforation are the most life threatening. \u0000Materials and methods: Case files from the Department of Surgery were retrieved and studied. Patients were contacted telephonically for details of drug abuse history. These were then further studied in detail. \u0000Results: Forty-eight (68 percent) patients out of a total of 78 had a history of drug abuse. The most commonly abused pain killer was a combination of anti-inflammatory and other salts, which was found in 22 (46 percent) patients, followed by tramadol, NSAIDs, opium, and alcohol (23, 17, 10, and 4 percent, respectively). These groups were comparable in socio-demographic details except in the mean age, occupation, and gender distribution, and the difference was significant (p < 0.01). The most common cause for starting to use any of the above-mentioned pain killer was persistent pain. The most common site of obstruction in drug abusers was the stomach (60 percent), followed by the small intestine (38 percent) and the large intestine (2 percent). \u0000Limitations: (1) This is an observational retrospective record review. (2) Records were studied in hospital settings, so results should be generalized cautiously. (3) Risk of recall bias is present. \u0000Conclusion: Pain killers should always be prescribed with caution and for a short duration. Alternative options for pain relief should be made available, and doctors should be trained. Drug abusers tend to have a gastrointestinal complication at an early age, which means they are prone to further complications and recurrence if the problem is not addressed on time.","PeriodicalId":16601,"journal":{"name":"Journal of opioid management","volume":" 14","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139792569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tianeptine as an opiate replacement in a patient on methadone treatment: A case report 将替奈普汀作为美沙酮治疗患者的鸦片制剂替代品:病例报告
Q3 Medicine Pub Date : 2024-02-08 DOI: 10.5055/jom.0851
Vivek Velagapudi, Jordan Calabrese, Roopa Sethi
Tianeptine, an antidepressant and full μ-opioid receptor agonist, has increased in popularity and has been used as an over-the-counter supplement over the past decade. Due to its well-documented euphoric effects, there exists elevated risk for potential abuse. Buprenorphine–naloxone has been successfully utilized to treat opioid use disorder (OUD) in patients concurrently using tianeptine, limiting withdrawal symptoms and abstinence. However, there is limited evidence on the management of tianeptine use disorder, specifically methadone or naltrexone. The current opioid epidemic, the emerging use of tianeptine, and the lack of physician awareness have emphasized the need for further research on the role of tianeptine in medication-assisted treatment for OUD. This case report aims to demonstrate how medication-assisted therapy can be successfully utilized in a patient with opioid and severe other (tianeptine) drug use disorder.
替奈普汀(Tianeptine)是一种抗抑郁药和全μ-阿片受体激动剂,在过去十年中越来越受欢迎,并被用作非处方补充剂。由于其兴奋作用证据确凿,因此存在潜在滥用的高风险。丁丙诺啡-纳洛酮已被成功用于治疗同时使用替奈普汀的患者的阿片类药物使用障碍(OUD),从而限制戒断症状和戒断。然而,关于噻奈普汀使用障碍的治疗,特别是美沙酮或纳曲酮的治疗,目前证据有限。当前阿片类药物的流行、噻奈普汀的新兴用途以及医生对其认识的不足,都强调了进一步研究噻奈普汀在药物辅助治疗 OUD 中的作用的必要性。本病例报告旨在展示药物辅助治疗如何成功用于阿片类药物和严重其他(噻奈普汀)药物使用障碍患者。
{"title":"Tianeptine as an opiate replacement in a patient on methadone treatment: A case report","authors":"Vivek Velagapudi, Jordan Calabrese, Roopa Sethi","doi":"10.5055/jom.0851","DOIUrl":"https://doi.org/10.5055/jom.0851","url":null,"abstract":"Tianeptine, an antidepressant and full μ-opioid receptor agonist, has increased in popularity and has been used as an over-the-counter supplement over the past decade. Due to its well-documented euphoric effects, there exists elevated risk for potential abuse. Buprenorphine–naloxone has been successfully utilized to treat opioid use disorder (OUD) in patients concurrently using tianeptine, limiting withdrawal symptoms and abstinence. However, there is limited evidence on the management of tianeptine use disorder, specifically methadone or naltrexone. The current opioid epidemic, the emerging use of tianeptine, and the lack of physician awareness have emphasized the need for further research on the role of tianeptine in medication-assisted treatment for OUD. This case report aims to demonstrate how medication-assisted therapy can be successfully utilized in a patient with opioid and severe other (tianeptine) drug use disorder.","PeriodicalId":16601,"journal":{"name":"Journal of opioid management","volume":" 11","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139792730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An efficient LC-QTOF-mass spectrometry method for monitoring naltrexone compliance in urine of opioid-dependent subjects 监测阿片类药物依赖者尿液中纳曲酮顺应性的高效液相色谱-质谱法
Q3 Medicine Pub Date : 2024-02-08 DOI: 10.5055/jom.0841
Raka Jain, Piyali Mandal, Sachin Rana
Naltrexone (NTX) is an orally effective opiate antagonist used in maintenance treatment for opiate dependence. Its utility is limited by the patient's noncompliance. The study aimed to develop an efficient method for the detection of NTX in urine by LC-QTOF-mass spectrometry (MS) and its application to NTX compliance in opioid-dependent subjects. Sample preparation included a dilution step and direct injection to LC-QTOF-MS. Chromatographic separation was achieved with a C-18 column using a mixture of mobile phase 0.1 percent formic acid in water and 0.1 percent formic acid in 95 percent methanol. The calibration curve was linear in the range 1-100 ng/mL with a correlation coefficient higher than 0.996. Precision and accuracy were acceptable, and the recovery efficiency range was 80-85 percent. The current LC-QTOF-MS method is simple, precise, sensitive, and can be used for monitoring NTX compliance among opioid-dependent subjects in a clinical setting.
纳曲酮(NTX)是一种口服有效的阿片类药物拮抗剂,用于阿片类药物依赖的维持治疗。由于患者的不依从性,该药物的作用受到了限制。本研究旨在开发一种利用 LC-QTOF 质谱法检测尿液中 NTX 的有效方法,并将其应用于阿片类药物依赖者 NTX 依从性的检测。样品制备包括稀释步骤和直接注入 LC-QTOF-MS。色谱分离采用 C-18 色谱柱,流动相为 0.1% 甲酸水溶液和 0.1% 甲酸 95% 甲醇混合液。校准曲线在 1-100 纳克/毫升范围内呈线性关系,相关系数高于 0.996。精密度和准确度均可接受,回收率范围为 80%-85%。目前的 LC-QTOF-MS 方法简单、精确、灵敏,可用于监测阿片类药物依赖者对 NTX 的临床依从性。
{"title":"An efficient LC-QTOF-mass spectrometry method for monitoring naltrexone compliance in urine of opioid-dependent subjects","authors":"Raka Jain, Piyali Mandal, Sachin Rana","doi":"10.5055/jom.0841","DOIUrl":"https://doi.org/10.5055/jom.0841","url":null,"abstract":"Naltrexone (NTX) is an orally effective opiate antagonist used in maintenance treatment for opiate dependence. Its utility is limited by the patient's noncompliance. The study aimed to develop an efficient method for the detection of NTX in urine by LC-QTOF-mass spectrometry (MS) and its application to NTX compliance in opioid-dependent subjects. Sample preparation included a dilution step and direct injection to LC-QTOF-MS. Chromatographic separation was achieved with a C-18 column using a mixture of mobile phase 0.1 percent formic acid in water and 0.1 percent formic acid in 95 percent methanol. The calibration curve was linear in the range 1-100 ng/mL with a correlation coefficient higher than 0.996. Precision and accuracy were acceptable, and the recovery efficiency range was 80-85 percent. The current LC-QTOF-MS method is simple, precise, sensitive, and can be used for monitoring NTX compliance among opioid-dependent subjects in a clinical setting.","PeriodicalId":16601,"journal":{"name":"Journal of opioid management","volume":"10 18","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139851507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Volume 10, Number 5 第 10 卷第 5 号
Q3 Medicine Pub Date : 2024-01-10 DOI: 10.5055/jom.2014.0227
Journal of Opioid Management
September/October 2014
2014 年 9 月/10 月
{"title":"Volume 10, Number 5","authors":"Journal of Opioid Management","doi":"10.5055/jom.2014.0227","DOIUrl":"https://doi.org/10.5055/jom.2014.0227","url":null,"abstract":"September/October 2014","PeriodicalId":16601,"journal":{"name":"Journal of opioid management","volume":"9 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139439937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Volume 19, Number 5 第 19 卷,第 5 号
Q3 Medicine Pub Date : 2023-11-20 DOI: 10.5055/jom.0820
Geoffrey E. Hinton, R. Gartner, Jessica Bundy, Maria Jung, Tyler J King, Jane B. Sprott, Fernando Ávila, J. Briggs, Daniel Konikof, Alex Luscombe, Audrey Macklin, H. Pelvin
September/October 2023
2023 年 9 月/10 月
{"title":"Volume 19, Number 5","authors":"Geoffrey E. Hinton, R. Gartner, Jessica Bundy, Maria Jung, Tyler J King, Jane B. Sprott, Fernando Ávila, J. Briggs, Daniel Konikof, Alex Luscombe, Audrey Macklin, H. Pelvin","doi":"10.5055/jom.0820","DOIUrl":"https://doi.org/10.5055/jom.0820","url":null,"abstract":"September/October 2023","PeriodicalId":16601,"journal":{"name":"Journal of opioid management","volume":"11 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139257421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erector spinae plane block for radiofrequency ablation of hepatic focal lesions: Randomized controlled trial. 肝灶病变射频消融的脊柱后凸平面阻滞:随机对照试验
Q3 Medicine Pub Date : 2023-11-01 DOI: 10.5055/jom.0838
Mona Raafat Elghamry, Mohamed Ahmed Lotfy, Kareem Mohammed Ramadan, Mohammad Ali Abduallah

Objective: This study evaluated the opioid sparing and pain relief effect of erector spinae plane block (ESPB) for radiofrequency ablation (RFA) of hepatic focal lesions under conscious sedation.

Design: A randomized controlled trial.

Setting: Tanta University Hospitals.

Patients: Fifty patients aged 30-60 years old and eligible for RFA of hepatic focal lesions were included.

Interventions: Patients randomized to receive either local anesthetic infiltration (group I) or ESPB (group II). Both groups received sedation by propofol infusion.

Main outcome measure(s): The primary outcome was total fentanyl consumption. Secondary outcomes were nonverbal pain score (NVPS), time to first analgesic request post-procedure, radiologist's satisfaction, and complications.

Results: In group I, NVPS was significantly increased at 10, 15, 25, and 30 minutes during RFA compared to group II (p = 0.008, <0.001, 0.018, and 0.001, respectively) with no significant differences on arrival to post-anesthesia care unit (PACU) and after 1 hour. Total fentanyl consumption during the procedure was significantly increased in group I compared to group II (160.9 ± 38.2 and 76 ± 21 µg, respectively; p < 0.001) with prolonged time to first analgesia request post-procedure in group II compared to group I (392.7 ± 38.8 and 101.1 ± 13.6 minutes, respectively; p < 0.001). The level of radiologist's satisfaction was significantly increased in the group II (p = 0.010). Three patients in group I and one patient in group II needed general anesthesia. Lower incidence of complications in group II occurred with statistical insignificance.

Conclusions: The ESPB provided adequate analgesia and reduced opioids consumption during the hepatic RFA, with high radiologist's satisfaction.

目的:本研究评估了在有意识镇静状态下使用直立肌脊柱平面阻滞(ESPB)对肝灶病变进行射频消融(RFA)的阿片类药物稀释和镇痛效果:随机对照试验:坦塔大学医院:纳入 50 名年龄在 30-60 岁之间、符合肝脏病灶射频消融术条件的患者:患者随机接受局部麻醉浸润(I组)或ESPB(II组)。两组患者均接受异丙酚输注镇静:主要结果是芬太尼总用量。次要结果是非言语疼痛评分(NVPS)、术后首次要求镇痛的时间、放射科医生的满意度和并发症:结果:与第二组相比,第一组在 RFA 过程中 10、15、25 和 30 分钟时的 NVPS 均明显增加(P = 0.008):ESPB提供了充分的镇痛,减少了肝脏RFA过程中阿片类药物的用量,放射科医生的满意度很高。
{"title":"Erector spinae plane block for radiofrequency ablation of hepatic focal lesions: Randomized controlled trial.","authors":"Mona Raafat Elghamry, Mohamed Ahmed Lotfy, Kareem Mohammed Ramadan, Mohammad Ali Abduallah","doi":"10.5055/jom.0838","DOIUrl":"10.5055/jom.0838","url":null,"abstract":"<p><strong>Objective: </strong>This study evaluated the opioid sparing and pain relief effect of erector spinae plane block (ESPB) for radiofrequency ablation (RFA) of hepatic focal lesions under conscious sedation.</p><p><strong>Design: </strong>A randomized controlled trial.</p><p><strong>Setting: </strong>Tanta University Hospitals.</p><p><strong>Patients: </strong>Fifty patients aged 30-60 years old and eligible for RFA of hepatic focal lesions were included.</p><p><strong>Interventions: </strong>Patients randomized to receive either local anesthetic infiltration (group I) or ESPB (group II). Both groups received sedation by propofol infusion.</p><p><strong>Main outcome measure(s): </strong>The primary outcome was total fentanyl consumption. Secondary outcomes were nonverbal pain score (NVPS), time to first analgesic request post-procedure, radiologist's satisfaction, and complications.</p><p><strong>Results: </strong>In group I, NVPS was significantly increased at 10, 15, 25, and 30 minutes during RFA compared to group II (p = 0.008, <0.001, 0.018, and 0.001, respectively) with no significant differences on arrival to post-anesthesia care unit (PACU) and after 1 hour. Total fentanyl consumption during the procedure was significantly increased in group I compared to group II (160.9 ± 38.2 and 76 ± 21 µg, respectively; p < 0.001) with prolonged time to first analgesia request post-procedure in group II compared to group I (392.7 ± 38.8 and 101.1 ± 13.6 minutes, respectively; p < 0.001). The level of radiologist's satisfaction was significantly increased in the group II (p = 0.010). Three patients in group I and one patient in group II needed general anesthesia. Lower incidence of complications in group II occurred with statistical insignificance.</p><p><strong>Conclusions: </strong>The ESPB provided adequate analgesia and reduced opioids consumption during the hepatic RFA, with high radiologist's satisfaction.</p>","PeriodicalId":16601,"journal":{"name":"Journal of opioid management","volume":"19 6","pages":"533-541"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139377838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Opioid prescription patterns in a children's hospital from 2012 to 2016. 2012 年至 2016 年一家儿童医院的阿片类药物处方模式。
Q3 Medicine Pub Date : 2023-11-01 DOI: 10.5055/jom.0833
Nicole Titze, Rishi Bhargava, Ara Jamasbi Montalvo, Gawon Shin, Campbell Belisle Haley, Soheil Saadat, Bharath Chakravarthy

Study objective: Pain management is a widely discussed topic, especially in the setting of the current opioid epidemic. Previous studies have shown that the use of opioids increased in the adult population. We aimed to look at the use of narcotic and non-narcotic pain medications at a large pediatric hospital to discern if patterns of pediatric pain management changed over time.

Methods: 58,402 analgesic prescriptions of patients 0-21 years of age were analyzed from May 2012 to November 2016. A logistic regression model was fitted to examine the association of age, sex, primary diagnosis, and the length of hospital stay with probability of opioid prescription.

Results: 36,560 patients aged 0-21 years (mean: 10.5, median: 11.0, and standard deviation (SD): 7.42) received analgesic pain medications. 21,847 (59.8 percent) patients were prescribed more than one analgesic. There was a male predominance in patients <15 years of age; however, in adolescents >16 years, females constituted 57.1 percent of patients. Data also showed a statistically significant reduction of opioid prescriptions from 2012 to 2016 (p < 0.001). Age and length of hospital stay were directly associated with opioid prescription (p < 0.001).

Conclusion: Data show that there is a decrease in overall opioid prescriptions among pediatric patients, which may be secondary to new Food and Drug Administration regulations and increased awareness of morbidity associated with opioid use. Not surprisingly, increased hospital stay and increase in age lead to more analgesic prescriptions. Further investigation is needed to determine the differences within opioid prescription patterns.

研究目的:疼痛管理是一个被广泛讨论的话题,尤其是在当前阿片类药物流行的背景下。以往的研究表明,阿片类药物的使用在成年人群中有所增加。我们旨在调查一家大型儿科医院麻醉性和非麻醉性止痛药物的使用情况,以了解儿科疼痛管理模式是否随着时间的推移而发生变化。方法:我们分析了 2012 年 5 月至 2016 年 11 月期间 0-21 岁患者的 58402 份镇痛处方。采用逻辑回归模型研究年龄、性别、主要诊断和住院时间与阿片类药物处方概率的关系:结果:36560 名 0-21 岁的患者(平均年龄:10.5 岁,中位数:10.5 岁)被处方阿片类药物:结果:36,560 名 0-21 岁的患者(平均值:10.5,中位数:11.0,标准偏差(±0.9))被处方阿片类药物:结果:36560 名 0-21 岁的患者(平均值:10.5,中位值:11.0,标准差(SD):7.42)接受了镇痛药物治疗。21,847 名患者(59.8%)服用了一种以上的镇痛药。16 岁患者中男性居多,女性占 57.1%。数据还显示,从2012年到2016年,阿片类药物的处方量出现了统计学意义上的显著减少(p < 0.001)。年龄和住院时间与阿片类药物处方直接相关(p < 0.001):数据显示,儿科患者的阿片类药物处方总量有所减少,这可能与食品药品管理局的新规定以及人们对阿片类药物使用相关发病率的认识提高有关。毫不奇怪,住院时间的延长和年龄的增加会导致更多的镇痛剂处方。要确定阿片类药物处方模式的差异,还需要进一步的调查。
{"title":"Opioid prescription patterns in a children's hospital from 2012 to 2016.","authors":"Nicole Titze, Rishi Bhargava, Ara Jamasbi Montalvo, Gawon Shin, Campbell Belisle Haley, Soheil Saadat, Bharath Chakravarthy","doi":"10.5055/jom.0833","DOIUrl":"10.5055/jom.0833","url":null,"abstract":"<p><strong>Study objective: </strong>Pain management is a widely discussed topic, especially in the setting of the current opioid epidemic. Previous studies have shown that the use of opioids increased in the adult population. We aimed to look at the use of narcotic and non-narcotic pain medications at a large pediatric hospital to discern if patterns of pediatric pain management changed over time.</p><p><strong>Methods: </strong>58,402 analgesic prescriptions of patients 0-21 years of age were analyzed from May 2012 to November 2016. A logistic regression model was fitted to examine the association of age, sex, primary diagnosis, and the length of hospital stay with probability of opioid prescription.</p><p><strong>Results: </strong>36,560 patients aged 0-21 years (mean: 10.5, median: 11.0, and standard deviation (SD): 7.42) received analgesic pain medications. 21,847 (59.8 percent) patients were prescribed more than one analgesic. There was a male predominance in patients <15 years of age; however, in adolescents >16 years, females constituted 57.1 percent of patients. Data also showed a statistically significant reduction of opioid prescriptions from 2012 to 2016 (p < 0.001). Age and length of hospital stay were directly associated with opioid prescription (p < 0.001).</p><p><strong>Conclusion: </strong>Data show that there is a decrease in overall opioid prescriptions among pediatric patients, which may be secondary to new Food and Drug Administration regulations and increased awareness of morbidity associated with opioid use. Not surprisingly, increased hospital stay and increase in age lead to more analgesic prescriptions. Further investigation is needed to determine the differences within opioid prescription patterns.</p>","PeriodicalId":16601,"journal":{"name":"Journal of opioid management","volume":"19 6","pages":"489-494"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139377839","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patients with glenohumeral arthritis are more likely to be prescribed opioids in the emergency department or urgent care setting. 盂肱关节炎患者更有可能在急诊室或紧急护理环境中获得阿片类药物处方。
Q3 Medicine Pub Date : 2023-11-01 DOI: 10.5055/jom.0834
Jacob Gorbaty, Meghan K Wally, Susan Odum, Ziqing Yu, Nady Hamid, Joseph R Hsu, Michael Beuhler, Michael Bosse, Michael Gibbs, Christopher Griggs, Steven Jarrett, Madhav Karunakar, Laurence Kempton, Daniel Leas, Kevin Phelps, Tamar Roomian, Michael Runyon, Animita Saha, Stephen Sims, Brad Watling, Stephen Wyatt, Rachel Seymour

Objective: The objective is to quantify the rate of opioid and benzodiazepine prescribing for the diagnosis of shoulder osteoarthritis across a large healthcare system and to describe the impact of a clinical decision support intervention on prescribing patterns.

Design: A prospective observational study.

Setting: One large healthcare system.

Patients and participants: Adult patients presenting with shoulder osteoarthritis.

Interventions: A clinical decision support intervention that presents an alert to prescribers when patients meet criteria for increased risk of opioid use disorder.

Main outcome measure: The percentage of patients receiving an opioid or benzodiazepine, the percentage who had at least one risk factor for misuse, and the percent of encounters in which the prescribing decision was influenced by the alert were the main outcome measures.

Results: A total of 5,380 outpatient encounters with a diagnosis of shoulder osteoarthritis were included. Twenty-nine percent (n = 1,548) of these encounters resulted in an opioid or benzodiazepine prescription. One-third of those who received a prescription had at least one risk factor for prescription misuse. Patients were more likely to receive opioids from the emergency department or urgent care facilities (40 percent of encounters) compared to outpatient facilities (28 percent) (p < .0001). Forty-four percent of the opioid prescriptions were for "potent opioids" (morphine milliequivalent conversion factor > 1). Of the 612 encounters triggering an alert, the prescribing decision was influenced (modified or not prescribed) in 53 encounters (8.7 percent). All but four (0.65 percent) of these encounters resulted in an opioid prescription.

Conclusion: Despite evidence against routine opioid use for osteoarthritis, one-third of patients with a primary diagnosis of glenohumeral osteoarthritis received an opioid prescription. Of those who received a prescription, over one-third had a risk factor for opioid misuse. An electronic clinic decision support tool influenced the prescription in less than 10 percent of encounters.

目标:目的:量化大型医疗系统中为诊断肩关节骨关节炎而开具阿片类药物和苯二氮卓类药物处方的比例,并描述临床决策支持干预对处方模式的影响:设计:前瞻性观察研究:一个大型医疗系统:患者和参与者:患有肩关节骨关节炎的成年患者:主要结果测量指标:接受阿片类药物或苯二氮卓类药物治疗的患者比例、至少有一个滥用风险因素的患者比例以及处方决定受该警报影响的就诊比例:共纳入了 5380 例诊断为肩关节骨关节炎的门诊病例。其中 29% 的患者(n=1,548)开出了阿片类药物或苯二氮卓类药物处方。在开出处方的患者中,有三分之一至少有一个处方滥用的风险因素。与门诊机构(28%)相比,患者更有可能从急诊科或紧急护理机构(40%)获得阿片类药物(p < .0001)。44%的阿片类药物处方为 "强效阿片类药物"(吗啡毫当量换算系数大于 1)。在触发警报的 612 个病例中,有 53 个病例(8.7%)的处方决定受到影响(修改或不开具)。除 4 例(0.65%)外,其余均开出了阿片类处方:结论:尽管有证据表明骨关节炎不宜常规使用阿片类药物,但三分之一的主要诊断为盂肱骨骨关节炎的患者接受了阿片类药物处方。在接受处方治疗的患者中,超过三分之一存在滥用阿片类药物的风险因素。电子门诊决策支持工具对处方产生影响的比例不到 10%。
{"title":"Patients with glenohumeral arthritis are more likely to be prescribed opioids in the emergency department or urgent care setting.","authors":"Jacob Gorbaty, Meghan K Wally, Susan Odum, Ziqing Yu, Nady Hamid, Joseph R Hsu, Michael Beuhler, Michael Bosse, Michael Gibbs, Christopher Griggs, Steven Jarrett, Madhav Karunakar, Laurence Kempton, Daniel Leas, Kevin Phelps, Tamar Roomian, Michael Runyon, Animita Saha, Stephen Sims, Brad Watling, Stephen Wyatt, Rachel Seymour","doi":"10.5055/jom.0834","DOIUrl":"10.5055/jom.0834","url":null,"abstract":"<p><strong>Objective: </strong>The objective is to quantify the rate of opioid and benzodiazepine prescribing for the diagnosis of shoulder osteoarthritis across a large healthcare system and to describe the impact of a clinical decision support intervention on prescribing patterns.</p><p><strong>Design: </strong>A prospective observational study.</p><p><strong>Setting: </strong>One large healthcare system.</p><p><strong>Patients and participants: </strong>Adult patients presenting with shoulder osteoarthritis.</p><p><strong>Interventions: </strong>A clinical decision support intervention that presents an alert to prescribers when patients meet criteria for increased risk of opioid use disorder.</p><p><strong>Main outcome measure: </strong>The percentage of patients receiving an opioid or benzodiazepine, the percentage who had at least one risk factor for misuse, and the percent of encounters in which the prescribing decision was influenced by the alert were the main outcome measures.</p><p><strong>Results: </strong>A total of 5,380 outpatient encounters with a diagnosis of shoulder osteoarthritis were included. Twenty-nine percent (n = 1,548) of these encounters resulted in an opioid or benzodiazepine prescription. One-third of those who received a prescription had at least one risk factor for prescription misuse. Patients were more likely to receive opioids from the emergency department or urgent care facilities (40 percent of encounters) compared to outpatient facilities (28 percent) (p < .0001). Forty-four percent of the opioid prescriptions were for \"potent opioids\" (morphine milliequivalent conversion factor > 1). Of the 612 encounters triggering an alert, the prescribing decision was influenced (modified or not prescribed) in 53 encounters (8.7 percent). All but four (0.65 percent) of these encounters resulted in an opioid prescription.</p><p><strong>Conclusion: </strong>Despite evidence against routine opioid use for osteoarthritis, one-third of patients with a primary diagnosis of glenohumeral osteoarthritis received an opioid prescription. Of those who received a prescription, over one-third had a risk factor for opioid misuse. An electronic clinic decision support tool influenced the prescription in less than 10 percent of encounters.</p>","PeriodicalId":16601,"journal":{"name":"Journal of opioid management","volume":"19 6","pages":"495-505"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139377842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical prescription opioid trajectories among state Medicaid enrollees. 州医疗补助参保者的阿片类药物手术处方轨迹。
Q3 Medicine Pub Date : 2023-11-01 DOI: 10.5055/jom.0832
Jenna L McCauley, Ralph C Ward, David J Taber, William T Basco, Mulugeta Gebregziabher, Charles Reitman, William P Moran, Robert A Cina, Mark A Lockett, Sarah J Ball

Objective: The objective of this study was to evaluate opioid use trajectories among a sample of 10,138 Medicaid patients receiving one of six index surgeries: lumbar spine, total knee arthroplasty, cholecystectomy, appendectomy, colon resection, and tonsillectomy.

Design: Retrospective cohort.

Setting: Administrative claims data.

Patients and participants: Patients, aged 13 years and older, with 15-month continuous Medicaid eligibility surrounding index surgery, were selected from single-state Medicaid medical and pharmacy claims data for surgeries performed between 2014 and 2017.

Interventions: None.

Main outcome measures: Baseline comorbidities and presurgery opioid use were assessed in the 6 months prior to admission, and patients' opioid use was followed for 9 months post-discharge. Generalized linear model with log link and Poisson distribution was used to determine risk of chronic opioid use for all risk factors. Group-based trajectory models identified groups of patients with similar opioid use trajectories over the 15-month study period.

Results: More than one in three (37.7 percent) patients were post-surgery chronic opioid users, defined as the dichotomous outcome of filling an opioid prescription 90 or more days after surgery. Key variables associated with chronic post-surgery opioid use include presurgery opioid use, 30-day post-surgery opioid use, and comorbidities. Latent trajectory modeling grouped patients into six distinct opioid use trajectories. Associates of trajectory group membership are reported.

Conclusions: Findings support the importance of surgeons setting realistic patient expectations for post-surgical opioid use, as well as the importance of coordination of post-surgical care among patients failing to fully taper off opioids within 1-3 months of surgery.

研究目的本研究旨在对接受腰椎手术、全膝关节置换术、胆囊切除术、阑尾切除术、结肠切除术和扁桃体切除术等六种指标手术之一的10138名医疗补助患者的阿片类药物使用轨迹进行评估:设计:回顾性队列:患者和参与者从2014年至2017年期间实施手术的单州医疗补助医疗和药房报销数据中选取年龄在13岁及以上、在索引手术前后连续15个月符合医疗补助资格的患者:主要结果测量:入院前6个月对基线合并症和手术前阿片类药物使用情况进行评估,出院后9个月对患者阿片类药物使用情况进行随访。采用具有对数链接和泊松分布的广义线性模型来确定所有风险因素导致长期使用阿片类药物的风险。基于群体的轨迹模型确定了15个月研究期间阿片类药物使用轨迹相似的患者群体:超过三分之一(37.7%)的患者为术后长期阿片类药物使用者,即术后 90 天或 90 天以上使用阿片类药物处方的二分法结果。与手术后长期使用阿片类药物相关的主要变量包括手术前阿片类药物使用情况、手术后 30 天阿片类药物使用情况和合并症。潜在轨迹模型将患者分为六种不同的阿片类药物使用轨迹。结论:研究结果表明,外科医生在确定患者的阿片类药物使用轨迹时必须考虑到患者的并发症:研究结果表明,外科医生必须为患者设定切合实际的术后阿片类药物使用期望值,对于未能在术后1-3个月内完全停用阿片类药物的患者,协调术后护理也很重要。
{"title":"Surgical prescription opioid trajectories among state Medicaid enrollees.","authors":"Jenna L McCauley, Ralph C Ward, David J Taber, William T Basco, Mulugeta Gebregziabher, Charles Reitman, William P Moran, Robert A Cina, Mark A Lockett, Sarah J Ball","doi":"10.5055/jom.0832","DOIUrl":"10.5055/jom.0832","url":null,"abstract":"<p><strong>Objective: </strong>The objective of this study was to evaluate opioid use trajectories among a sample of 10,138 Medicaid patients receiving one of six index surgeries: lumbar spine, total knee arthroplasty, cholecystectomy, appendectomy, colon resection, and tonsillectomy.</p><p><strong>Design: </strong>Retrospective cohort.</p><p><strong>Setting: </strong>Administrative claims data.</p><p><strong>Patients and participants: </strong>Patients, aged 13 years and older, with 15-month continuous Medicaid eligibility surrounding index surgery, were selected from single-state Medicaid medical and pharmacy claims data for surgeries performed between 2014 and 2017.</p><p><strong>Interventions: </strong>None.</p><p><strong>Main outcome measures: </strong>Baseline comorbidities and presurgery opioid use were assessed in the 6 months prior to admission, and patients' opioid use was followed for 9 months post-discharge. Generalized linear model with log link and Poisson distribution was used to determine risk of chronic opioid use for all risk factors. Group-based trajectory models identified groups of patients with similar opioid use trajectories over the 15-month study period.</p><p><strong>Results: </strong>More than one in three (37.7 percent) patients were post-surgery chronic opioid users, defined as the dichotomous outcome of filling an opioid prescription 90 or more days after surgery. Key variables associated with chronic post-surgery opioid use include presurgery opioid use, 30-day post-surgery opioid use, and comorbidities. Latent trajectory modeling grouped patients into six distinct opioid use trajectories. Associates of trajectory group membership are reported.</p><p><strong>Conclusions: </strong>Findings support the importance of surgeons setting realistic patient expectations for post-surgical opioid use, as well as the importance of coordination of post-surgical care among patients failing to fully taper off opioids within 1-3 months of surgery.</p>","PeriodicalId":16601,"journal":{"name":"Journal of opioid management","volume":"19 6","pages":"465-488"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139377845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of opioid management
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1